U.S. Markets closed

Alnylam Pharmaceuticals, Inc. (ALNY)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
65.80-3.70 (-5.32%)
At close: 4:00PM EDT
People also watch
BMRNACORSGENACADALXN
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2017)Next Qtr. (Sep 2017)Current Year (2017)Next Year (2018)
No. of Analysts13131514
Avg. Estimate-1.23-1.33-5.34-4.99
Low Estimate-1.46-1.7-6.43-6.2
High Estimate-1.03-1.12-4.63-3.1
Year Ago EPS-1.05-1.21-4.79-5.34
Revenue EstimateCurrent Qtr. (Jun 2017)Next Qtr. (Sep 2017)Current Year (2017)Next Year (2018)
No. of Analysts13131615
Avg. Estimate22.76M21.58M77.45M147.33M
Low Estimate2M2M25M46.18M
High Estimate39M37M106M274.7M
Year Ago Sales8.71M13.65M47.16M77.45M
Sales Growth (year/est)161.30%58.10%64.20%90.20%
Earnings History6/29/20169/29/201612/30/20163/30/2017
EPS Est.-1.24-1.14-1.34-1.26
EPS Actual-1.05-1.21-1.32-1.25
Difference0.19-0.070.020.01
Surprise %15.30%-6.10%1.50%0.80%
EPS TrendCurrent Qtr. (Jun 2017)Next Qtr. (Sep 2017)Current Year (2017)Next Year (2018)
Current Estimate-1.23-1.33-5.34-4.99
7 Days Ago-1.23-1.34-5.35-5.02
30 Days Ago-1.25-1.38-5.19-4.46
60 Days Ago-1.28-1.41-5.1-4.39
90 Days Ago-1.3-1.4-5.09-4.74
EPS RevisionsCurrent Qtr. (Jun 2017)Next Qtr. (Sep 2017)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/A112
Up Last 30 Days7968
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesALNYIndustrySectorS&P 500
Current Qtr.-17.10%N/AN/A0.20
Next Qtr.-9.90%N/AN/A0.21
Current Year-11.50%N/AN/A0.09
Next Year6.60%N/AN/A0.12
Next 5 Years (per annum)46.09%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A